Topic Archives - Kotter International Inc

European steel or cement plant representing CBAM-affected industries

AI + Digital Transformation Blog EMEA Energy + Natural Resources Kotter Insights Leading Through Crisis Manufacturing Operational Efficiency

CBAM Compliance Alone Is Not Enough

Compliance alone will not prepare companies for CBAM’s definitive phase. Leaders must mobilize cross-functional teams,…

Nick PetschekFebruary 23, 2026

Blog Education Employee Engagement Human Resources Innovation Kotter In The News Kotter Insights Leadership Development Technology Workplace

Skills Gaps Are at a Breaking Point

In a rapidly changing environment, highly specialized skills can quickly become obsolete. Instead, think about…

Rachel RosenfeldtFebruary 9, 2026

Counterfeit drugs are rising as viral demand outpaces regulation. Learn how pharma leaders can protect trust, safety, and innovation.

Blog EMEA Innovation Kotter In The News Kotter Insights Leadership Development Pharma + Biotech

Question of Trust: How Pharma Leaders Can Respond to Counterfeit Drug Risk

The news that Hein Schumacher is set to take over from Barry Callebaut CEO Peter…

Nick PetschekFebruary 2, 2026

Blog Culture Change EMEA Kotter In The News Kotter Insights Leading Through Crisis Retail

Barry Callebaut leadership reset – why and what come next?

The news that Hein Schumacher is set to take over from Barry Callebaut CEO Peter…

Nick PetschekJanuary 27, 2026

Pharmaceutical R+D has never been more technologically capable. Artificial analytics are accelerating discovery cycles in ways that were unimaginable a decade ago. Yet despite these advances, sustaining innovation has become harder than ever. Development costs are climbing, competition for talent is intensifying and many of the most exciting early-stage innovations are now coming from biotech and academic partners. At the same time, a new generation of scientists is entering the field with different expectations. They look for trust, adaptability and purpose, not rigid hierarchies and incremental progress.

Blog Culture Change EMEA Innovation Kotter In The News Kotter Insights Leadership Development Pharma + Biotech

The Future of Pharma R+D Leadership

Pharmaceutical R+D has never been more technologically capable. Artificial analytics are accelerating discovery cycles in…

Nick PetschekJanuary 27, 2026

For decades, leaders assumed uncertainty would pass. Today, uncertainty is constant. Organizations that succeed are those that build adaptability into their systems, culture, and leadership development.

Blog Culture Change Growth Kotter In The News Kotter Insights Leading Through Crisis Operational Efficiency Workplace

Leading During Permanent Uncertainty: How Training Can Help

The adoption of AI in drug development, patient care, operations, and health management has created…

Kathy GerschJanuary 26, 2026

From predictive maintenance and demand forecasting to warehouse automation and supplier risk management, the opportunities and pressure to adopt AI are mounting. Yet despite significant investments, many manufacturing and supply chain operations are struggling to see meaningful returns. The problem isn't the technology itself, it's with the question leaders are asking.

AI + Digital Transformation Blog Growth Innovation Kotter In The News Kotter Insights Leadership Development Manufacturing Operational Efficiency Supply Chain

Supply Chain Leaders: Stop Asking “What’s Our AI Strategy?”

From predictive maintenance and demand forecasting to warehouse automation and supplier risk management, the opportunities…

Dr. Vanessa AkhtarJanuary 26, 2026

AI + Digital Transformation Blog Culture Change EMEA Healthcare Innovation Kotter In The News Kotter Insights Pharma + Biotech Technology

When Innovation Outpaces Regulation

Addressing the threat of unlicensed drugs requires coordinated action across every industry tier, from pharma…

Nick PetschekJanuary 15, 2026

Blog Employee Engagement Government Kotter In The News Kotter Insights Leading Through Crisis Workplace

Beyond the Backlog: Rebuilding Trust and Performance in the Federal Workforce

The end of the longest government shutdown marked not a return to business-as-usual, but the…

Laurin ParthemosJanuary 8, 2026

Blog Employee Engagement Employee Retention Growth Kotter In The News Kotter Insights Leadership Development Operational Efficiency Workplace

From Bottlenecks to Breakthroughs: The Do’s and Don’ts of Empowering Leadership

The utility sector is navigating one of the most transformative periods in its history. Regulatory…

Leslie ZemnickJanuary 7, 2026

Topic

CBAM Compliance Alone Is Not Enough

Skills Gaps Are at a Breaking Point

Question of Trust: How Pharma Leaders Can Respond to Counterfeit Drug Risk

Barry Callebaut leadership reset – why and what come next?

The Future of Pharma R+D Leadership

Leading During Permanent Uncertainty: How Training Can Help

Supply Chain Leaders: Stop Asking “What’s Our AI Strategy?”

When Innovation Outpaces Regulation

Beyond the Backlog: Rebuilding Trust and Performance in the Federal Workforce

From Bottlenecks to Breakthroughs: The Do’s and Don’ts of Empowering Leadership

Work With Us

Learn With Us

Talk With Us